A study to assess pathological Complete response to neoadjuvant trastuzumab and pertuzumab therapy in patients HER2-positive breast cancer
Latest Information Update: 17 Dec 2020
At a glance
- Drugs Carboplatin (Primary) ; Docetaxel (Primary) ; Pertuzumab (Primary) ; Trastuzumab (Primary)
- Indications Breast cancer; Early breast cancer
- Focus Therapeutic Use
- 13 Nov 2020 Results published in the Medicine
- 09 Nov 2020 New trial record
- 03 Oct 2020 Results presented at the Official 12th European Breast Cancer Conference